Indian pharma companies in Ukraine face discrimination compared to other foreign companies – Indian ambassador
KYIV. Feb 28 (Interfax-Ukraine) – Indian pharmaceutical companies on the Ukrainian market are not in the equal conditions for doing business compared to companies from other countries, Ambassador of India to Ukraine Manoj Kumar Bharti said at a press conference at Interfax-Ukraine on Tuesday.
"At the moment of the arrival of Indian pharmaceutical products to a port they face a delay with customs agencies and supervising organizations. The European pharmaceutical products are examined quickly, while Indian products are examined for a long period of time. This results in delays with delivery of medicines. If Ukraine wants to benefit from good Indian pharmaceutical products it should pay attention to these moments," the ambassador said.
He also said that Indian pharmaceutical companies operating on the Ukrainian market face groundless inspections by law enforcement and regulatory agencies. The absence of grounds for too many inspections was proved in court many times.
In turn, President of Indian Pharmaceutical Manufacturers' Association in Ukraine (IPMA) Dr. Ramanan Menon also said that claims of law enforcers against Indian companies were groundless.
Dr Menon said that last year international organizations procured some generic products from Indian pharmaceutical manufacturers using Ukraine's budget funds, in particular, medicines to treat tuberculosis and AIDS.
He expressed hope that this year the range of medicines procured by international organizations for Ukraine would be increased.